Pacira BioSciences, Inc.
PCRX
$27.00
-$0.14-0.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 484.62M | 453.81M | 404.23M | 325.89M | 278.58M |
| Total Receivables | 113.80M | 100.95M | 104.78M | 101.74M | 105.96M |
| Inventory | 125.28M | 111.87M | 103.44M | 96.78M | 104.35M |
| Prepaid Expenses | 20.43M | 23.34M | 19.77M | 18.70M | 20.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.00M | -- | -- | -- | 700.00K |
| Total Current Assets | 745.13M | 689.97M | 632.21M | 543.11M | 509.99M |
|
|
|||||
| Total Current Assets | 745.13M | 689.97M | 632.21M | 543.11M | 509.99M |
| Net Property, Plant & Equipment | 216.39M | 220.68M | 225.11M | 230.43M | 234.95M |
| Long-term Investments | -- | -- | 163.24M | 163.24M | 163.24M |
| Goodwill | -- | -- | 163.24M | 163.24M | 163.24M |
| Total Other Intangibles | 425.97M | 440.29M | 454.61M | 468.94M | 483.26M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 136.58M | 134.02M | 135.14M | 141.06M | 150.69M |
| Total Assets | 1.55B | 1.52B | 1.65B | 1.58B | 1.57B |
|
|
|||||
| Total Accounts Payable | 19.13M | 19.37M | 18.73M | 8.98M | 15.70M |
| Total Accrued Expenses | 69.52M | 76.38M | 64.81M | 66.82M | 55.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 210.66M | 210.66M | 9.15M | 17.64M | 17.44M |
| Total Finance Division Other Current Liabilities | 10.61M | -- | -- | -- | 8.53M |
| Total Other Current Liabilities | 10.61M | -- | -- | -- | 8.53M |
| Total Current Liabilities | 309.92M | 306.40M | 92.69M | 93.44M | 97.38M |
|
|
|||||
| Total Current Liabilities | 309.92M | 306.40M | 92.69M | 93.44M | 97.38M |
| Long-Term Debt | 383.55M | 385.89M | 589.30M | 511.69M | 513.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.65M | 47.88M | 50.15M | 52.45M | 54.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.06M | 31.94M | 35.41M | 33.58M | 38.27M |
| Total Liabilities | 775.17M | 772.11M | 767.54M | 691.16M | 704.26M |
|
|
|||||
| Common Stock & APIC | 1.01B | 996.42M | 983.23M | 989.83M | 976.68M |
| Retained Earnings | -206.36M | -222.40M | -78.93M | -97.82M | -106.80M |
| Treasury Stock & Other | -24.78M | -24.44M | -25.02M | 152.00K | 247.00K |
| Total Common Equity | 778.35M | 749.58M | 879.28M | 892.16M | 870.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 778.35M | 749.58M | 879.28M | 892.16M | 870.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 778.35M | 749.58M | 879.28M | 892.16M | 870.13M |
|
|
|||||